Effective April 27, 2020, PathGroup is pleased to announce the availability of serologic testing for SARS-CoV-2, the pathogen associated with COVID-19. This new test is for the detection of human IgG antibodies against SARS-CoV-2 in serum or plasma.
To read more, click here.